164 related articles for article (PubMed ID: 36578802)
21. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
22. Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients.
Yuan M; Jia Y; Xing Y; Wang Y; Liu Y; Liu X; Liu D
Front Genet; 2022; 13():965033. PubMed ID: 36186426
[No Abstract] [Full Text] [Related]
23. Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer.
Xu F; Liu T; Zhou Z; Zou C; Xu S
Front Immunol; 2021; 12():749369. PubMed ID: 34745121
[TBL] [Abstract][Full Text] [Related]
24. Development and verification of a microsatellite instability-related risk signature for predicting survival and therapy effectiveness in gastric cancer.
Zhang T; Yu S; Zhao S
J Gastrointest Oncol; 2022 Feb; 13(1):84-101. PubMed ID: 35284118
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation-related lncRNAs predict prognosis and immunotherapy response in gastric cancer.
Guo X; Wang Y; Zha L; Li H; Qian K
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14745-14760. PubMed ID: 37592033
[TBL] [Abstract][Full Text] [Related]
26. Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer.
Li X; Dong H; Chen L; Wang Y; Hao Z; Zhang Y; Jiao Y; Zhao Z; Peng X; Zhan X
Front Immunol; 2022; 13():984149. PubMed ID: 36300121
[TBL] [Abstract][Full Text] [Related]
27. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
Li R; Zhao W; Liang R; Jin C; Xiong H
Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
[No Abstract] [Full Text] [Related]
28. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
Wang F; Chen C; Chen WP; Li ZL; Cheng H
Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
[TBL] [Abstract][Full Text] [Related]
29. Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer.
Guo X; Liang X; Wang Y; Cheng A; Zhang H; Qin C; Wang Z
Front Genet; 2021; 12():642608. PubMed ID: 34306002
[TBL] [Abstract][Full Text] [Related]
30. Immune-related gene signature predicts overall survival of gastric cancer patients with varying microsatellite instability status.
Tian R; Hu J; Ma X; Liang L; Guo S
Aging (Albany NY); 2020 Dec; 13(2):2418-2435. PubMed ID: 33316777
[TBL] [Abstract][Full Text] [Related]
31. Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients.
Gao J; Huo S; Zhang Y; Zhao Z; Pan H; Liu X
Cancer Med; 2023 Jan; 12(1):913-929. PubMed ID: 35621244
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
Bao X; Zhang H; Wu W; Cheng S; Dai X; Zhu X; Fu Q; Tong Z; Liu L; Zheng Y; Zhao P; Fang W; Liu F
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028695
[TBL] [Abstract][Full Text] [Related]
33. DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer.
Dai J; Jiang M; He K; Wang H; Chen P; Guo H; Zhao W; Lu H; He Y; Zhou C
Front Oncol; 2021; 11():708294. PubMed ID: 34604048
[TBL] [Abstract][Full Text] [Related]
34. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
[TBL] [Abstract][Full Text] [Related]
35. Five EMT-related genes signature predicts overall survival and immune environment in microsatellite instability-high gastric cancer.
Zhang M; Cao C; Li X; Gu Q; Xu Y; Zhu Z; Xu D; Wei S; Chen H; Yang Y; Gao H; Yu L; Li J
Cancer Med; 2023 Jan; 12(2):2075-2088. PubMed ID: 35789544
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
37. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
Wang Z; Liu H; Gong Y; Cheng Y
Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
[TBL] [Abstract][Full Text] [Related]
38. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma.
Meijing Z; Tianhang L; Biao Y
Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200
[No Abstract] [Full Text] [Related]
39. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
40. Uncover DNA damage and repair-related gene signature and risk score model for glioma.
Wu Y; Liu L; Huang D; Li Z; Xu R; Cheng M; Chen L; Wang Q; You C
Ann Med; 2023 Dec; 55(1):2200033. PubMed ID: 37086071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
